Published on
November 16, 2023
- 16:57 GMT
Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act
Docket Number: FDA-2022-D-0053 Issued by: Guidance Issuing Office Center for Devices and Radiological Health Center for Biologics Evaluation and Research The Food and Drug Administration (FDA or Agency) is issuing this guidance to address section 506J of …
Distribution channels:
